Jim Cramer Says “I like Cencora A Lot” But Notes “Cardinal Health’s Got Them All Beat”

• StockStory Top Pick COR +0.10% MCK +1.20%
• CAH +1.93%

Cencora, Inc. (NYSE:COR) is one of the stocks Jim Cramer recently discussed. During the lightning round, a caller inquired about Cramer’s thoughts on the stock, and he commented:

“Okay, I like Cencora a lot. But I got to tell you, I think this Cardinal Health’s got them all beat. Jason Hollar is a visionary. I like that guy.”

Source: Unsplash

Cencora, Inc. (NYSE:COR) distributes pharmaceuticals, vaccines, plasma products, and healthcare supplies. The company also provides supports clinical trials, specialty distribution, animal health products, and biopharmaceutical transportation. During the May 14 episode, Cramer mentioned the stock and said:

“These stocks, namely Cardinal Health, Cencora, and McKesson, are seemingly perpetual residents on the new high list. Over the long haul, they’re some of the best performers out there, and they’ve done great this year, as is pretty much always the case. And yet, doesn’t it always feel like the drug distributors are just one bad day away from falling apart… Cencora… knocked it out of the park when they reported last Wednesday… Posted a slight top line miss but monster 31 cent earnings beat off of $4 [and] 11 cent basis.

While we acknowledge the potential of COR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.